Content Hub
Preclinical Development of 212Pb-DOTAMTATE in a Neuroendocrine Tumor Model
Amal Saidi, Scientist, OranoMed
Want to see the exciting line-up for 2020?
Targeted alpha therapy with212Pb-NNV003 for thetreatmentof CD37 positive B-cellChronicLymphocyticLeukemia(CLL) and Non-HodgkinLymphoma(NHL)
Jostein Dahle
